Table 1 Baseline clinicodemographic characteristics of the modeling cohort
| Â | All | Non-OSA group | OSA group | p value |
|---|---|---|---|---|
Patients (n) | 59 | 13 | 46 | Â |
Sex, Males/female | 48 (81.4)/11 (18.6) | 8 (61.5)/5 (38.5) | 40 (87.0)/6 (13.0) | 0.04 |
Age (years) | 44.3 ± 8.59 | 42.1 ± 6.78 | 44.9 ± 9.01 | 0.30 |
BMI (kg/m2) | 26.4 ± 3.0 | 24.4 ± 3.0 | 27.0 ± 2.7 |  < 0.01 |
Waist circumference (cm) | 86.3 ± 8.8 | 82.1 ± 6.6 | 87.4 ± 9.0 | 0.05 |
Diabetes | 4 (6.8) | 0 (0.0) | 4 (8.7) | 0.27 |
Hypertension | 14 (23.7) | 2 (15.4) | 12 (26.1) | 0.42 |
AHI (events/h) | 16.7 (5.9–42.2) | 1.7 (0.6–3.0) | 23.9 (11.3–49.0) |  < 0.01 |
Mean SpO2 (%) | 96.1 (94.0–96.5) | 96.5 (96.2–97.0) | 95.8 (93.9–96.4) |  < 0.01 |
Minimal SpO2 (%) | 87.0 (80.0–92.0) | 93.0 (92.0–94.0) | 85.0 (75.0–90.0) |  < 0.01 |
ODI (events/h) | 12.3 (2.0–29.5) | 0.6 (0.0–1.4) | 20.1 (8.4–43.3) |  < 0.01 |
T90 (%) | 0.1 (0.0–1.9) | 0.0 (0.0–0.0) | 0.3 (0.0–2.9) |  < 0.01 |
ALT (IU/L) | 32.0 (21.0–44.0) | 23.0 (18.0–32.0) | 34.0 (22.0–48.0) | 0.09 |
AST (IU/L) | 26.0 (20.0–32.0) | 24.0 (21.0–27.0) | 27.0 (20.0–34.0) | 0.17 |
CAP (dB/m) | 269.4 ± 46.4 | 264.5 ± 47.8 | 270.8 ± 46.4 | 0.67 |
 Median | 262.0 (236.0–310.0) | 243.0 (240.0–304.0) | 262.5 (235.0–310.0) | 0.71 |
  ≥ 238 | 44 (74.6%) | 10 (76.9%) | 34 (73.9%) | 0.83 |
HSI | 37.4 ± 6.1 | 34.2 ± 4.5 | 38.3 ± 6.2 | 0.03 |
 Median | 37.5 (33.1–41.0) | 33.1 (32.1–37.1) | 38.2 (34.3–41.3) | 0.02 |
  > 36 | 37 (62.7%) | 6 (46.2%) | 31 (67.4%) | 0.16 |
LSM (kPa) | 5.3 (4.5–6.2) | 4.9 (4.1–5.7) | 5.6 (4.6–6.7) | 0.10 |